ClinicalTrials.Veeva

Menu

Medical Imaging in Bladder Tumors by MRI

Sun Yat-sen University logo

Sun Yat-sen University

Status

Enrolling

Conditions

Bladder Tumor
Magnetic Resonance Imaging

Treatments

Other: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT06033040
SYSKY-2023-549-01

Details and patient eligibility

About

This study prospectively included 178 patients with bladder neoplastic lesions who planned to undergo surgery (with or without preoperative neoadjuvant chemotherapy). Inclusion criteria: Patients with pathologically confirmed bladder cancer after radical or partial cystectomy or TURBT (< 2 weeks between surgical resection and imaging). Exclusion criteria: 1) Prior history of chemotherapy and/or radiotherapy; 2) No surgical resection; 3) The interval between surgical resection and imaging examination is > 2 weeks; 4) Obvious artifacts; 5)MRI scan contraindications. All subjects underwent pelvic MRI. Data was collected using a Siemens VIDA 3TMR scanner (Siemens Healthcare, Erlangen, Germany). All subjects underwent standardized scanning protocols. The obtained images are post-processed and the experimental results are analyzed statistically.

Enrollment

178 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Clinical diagnosis of bladder neoplasm
  2. Must undergo radical or partial cystectomy or TURBT surgery within 2 weeks between surgical resection and imaging

Exclusion criteria

  1. A history of pelvic radiotherapy or chemotherapy;
  2. Lack of pathological findings or no surgery;
  3. The interval between surgical resection and imaging examination > 2 weeks;
  4. Poor image quality due to poor coordination or motion artifacts;
  5. MRI scan contraindications

Trial contacts and locations

1

Loading...

Central trial contact

Yuan Luo, master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems